Felicis Deals

TypeSafe AI, developer of the Jev non-text decision model, raised $870 million at a $7.5 billion valuation to scale infrastructure and commercialization.

Arena raised a $200 million Series B round at a $3.1 billion valuation to expand its AI evaluation platform and launch the Arena Alignment Index.

Runlayer secured a $30 million Series A led by Felicis to expand its platform that provides centralized governance, visibility and control over the growing number of AI tools and agents used inside large enterprises.

Assort Health raised $120 million in Series C funding led by Menlo Ventures at a $1.2 billion valuation to scale its AI agent platform that automates patient access and administrative workflows for healthcare providers.